B. Riley Securities Maintains Buy on Nutex Health, Raises Price Target to $325

Benzinga Newsdesk www.benzinga.com Positive 80.9%

Neg 0% Neu 0% Pos 80.9%

B. Riley Securities analyst Yuan Zhi maintains Nutex Health (NASDAQ:NUTX) with a Buy and raises the price target from $290 to $325.